Get started
Author

Sarah Staggs

Observed name: Sarah E. Staggs
ORCID: 0009-0003-8283-055X
Observed ORCID: 0009-0003-8283-055X
OpenAlex ID: A5042401134
A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
2023 · Shanshan Pei, Ian T. Shelton, et al. · Cancer Discovery · 110
PDF
Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium
2024 · Anagha Inguva Sheth, Krysta Engel, et al. · Cancer Discovery · 50
PDF
Machine Learning–Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/Azacitidine
2022 · Nazmul Islam, Jamie S. Reuben, et al. · JCO Clinical Cancer Informatics · 11
Development of a dynamic counterfactual risk stratification strategy for newly diagnosed acute myeloid leukemia patients treated with venetoclax and azacitidine
2024 · Nazmul Islam, Justin L. Dale, et al. · medRxiv · 1
PDF
Targeting Mitochondrial Calcium Uptake to Eradicate Venetoclax-Resistant Acute Myeloid Leukemia Stem Cells
2023 · Anagha Inguva Sheth, Krysta Engel, et al. · Blood · 1
Supplementary Table 2 from A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
2025 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Figures S1-S7 from A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
2025 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Table 8 from A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
2025 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Table 6 from A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
2025 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Table 9 from A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
2025 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Tables 3-5 from A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
2025 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Table 7 from A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
2025 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Table 1 from A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
2025 · Shanshan Pei, Ian T. Shelton, et al.
Data from Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium
2024 · Anagha Inguva Sheth, Mark J. Althoff, et al.
Supplementary Tables S1-S3 from Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium
2024 · Anagha Inguva Sheth, Mark J. Althoff, et al.
Supplementary Figures S1-S6 from Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium
2024 · Anagha Inguva Sheth, Mark J. Althoff, et al.
Supplementary Table 6 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Table 6 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Table 7 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Table 7 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Figures S1-S7 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Figures S1-S7 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Table 1 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Tables 3-5 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · Shanshan Pei, Ian T. Shelton, et al.
Supplementary Table 1 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · Shanshan Pei, Ian T. Shelton, et al.
Works count: 51
Citation count: 173
H-index: 3
I10-index: 3
Year
Topic
Type